We are urging family members, or loved ones of US diabetics, who have developed bladder cancer, to ask if the bladder cancer victim was also using the drug called Actos
(PRWEB) December 12, 2011
The US Drug Watchdog says, "We are urging family members, or loved ones of US diabetics, who have developed bladder cancer, to ask if the bladder cancer victim was also using the drug called Actos. This is a very big deal, and we want to get every US diabetic, who was using Actos, and then developed bladder cancer identified. We do not think the average bladder cancer victim, who was also a diabetic would ever consider a drug for diabetics could have been a contributing factor for bladder cancer, so we are urging loved ones, or family members to ask the question. There may be a elevated incidence of bladder cancer for users of the diabetes drug called Actos, and we want to identify every US victim, in the hopes we can get them some meaningful help." Actos is a member of a class of drugs known as thiazolidinediones, which have been linked to bladder cancer. Actos side effects include increased risk of congestive heart failure, and an increased risk for bladder cancer. The US Drug Watchdog says, "We want to identify any user of the diabetes drug called Actos, if they have developed bladder cancer, and we think we will need the help of family members, and loved ones to get these victims identified." For more information please call the US Drug Watchdog anytime at 866-714-6466, or contact the group via their web site at http://USDrugWatchdog.Com
The US Drug Watchdog says, "One of the biggest problems we have with respect to our drug initiative work, is the average US consumer never hears about a drug recall, or serious side effects related to a specific drug's use. If you have a friend, or loved one, who was, or is using the diabetes drug called Actos, who has developed bladder cancer, please have them call us at 866-714-6466." http://USDrugWatchdog.Com
Case number 11cv2406 BEN BGS in the Federal District Court San Diego, CA.
# # #